156 related articles for article (PubMed ID: 10022555)
1. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.
Rainov NG; Ikeda K; Qureshi NH; Grover S; Herrlinger U; Pechan P; Chiocca EA; Breakefield XO; Barnett FH
Hum Gene Ther; 1999 Jan; 10(2):311-8. PubMed ID: 10022555
[TBL] [Abstract][Full Text] [Related]
2. Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms.
Rainov NG; Zimmer C; Chase M; Kramm CM; Chiocca EA; Weissleder R; Breakefield XO
Hum Gene Ther; 1995 Dec; 6(12):1543-52. PubMed ID: 8664379
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
[TBL] [Abstract][Full Text] [Related]
4. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
[TBL] [Abstract][Full Text] [Related]
5. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
[TBL] [Abstract][Full Text] [Related]
6. Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7.
Barnett FH; Rainov NG; Ikeda K; Schuback DE; Elliott P; Kramm CM; Chase M; Qureshi NH; Harsh G; Chiocca EA; Breakefield XO
Cancer Gene Ther; 1999; 6(1):14-20. PubMed ID: 10078959
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of HSV mass distribution in a rodent brain tumor model.
Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
[TBL] [Abstract][Full Text] [Related]
9. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
10. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells.
Viola JJ; Ram Z; Walbridge S; Oshiro EM; Trapnell B; Tao-Cheng JH; Oldfield EH
J Neurosurg; 1995 Jan; 82(1):70-6. PubMed ID: 7815137
[TBL] [Abstract][Full Text] [Related]
11. Transduction of rabbit saphenous artery: a comparison of naked DNA, liposome complexes, and adenovirus vectors.
Katsube K; Bishop AT; Friedrich PF
J Orthop Res; 2004 Nov; 22(6):1290-5. PubMed ID: 15475211
[TBL] [Abstract][Full Text] [Related]
12. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
13. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.
Nilaver G; Muldoon LL; Kroll RA; Pagel MA; Breakefield XO; Davidson BL; Neuwelt EA
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9829-33. PubMed ID: 7568227
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
Kramm CM; Chase M; Herrlinger U; Jacobs A; Pechan PA; Rainov NG; Sena-Esteves M; Aghi M; Barnett FH; Chiocca EA; Breakefield XO
Hum Gene Ther; 1997 Nov; 8(17):2057-68. PubMed ID: 9414254
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide.
Manome Y; Wen PY; Chen L; Tanaka T; Dong Y; Yamazoe M; Hirshowitz A; Kufe DW; Fine HA
Gene Ther; 1996 Jun; 3(6):513-20. PubMed ID: 8789801
[TBL] [Abstract][Full Text] [Related]
17. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S
Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087
[TBL] [Abstract][Full Text] [Related]
18. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
20. Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
Liu R; Martuza RL; Rabkin SD
Gene Ther; 2005 Apr; 12(8):647-54. PubMed ID: 15647762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
